drugset / Trial / NCT00732368
A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459)
NaSingle-groupOpen-labelTreatment
Summary
This study examined the safety and effectiveness of long-term administration of mometasone nasal spray in patients with perennial allergic rhinitis. Patients received mometasone for 12 weeks plus an additional 12 weeks if patient agreed to continue. Dose of mometasone could be decreased or increased during the study based on patient's response.
Timeline
- Start
- 2005-05-01
- Primary completion
- 2006-01-01
- Completion
- 2006-01-01
Publications
- Results T. Ishikawa et. al; Practica otologica. Suppl. 122 Page1-17(2008.11) -Japanese language journal
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mometasone furoate | Other / unclassified | 200 ug | Intranasal |